Folsom, California (PRWEB) June 05, 2013
Eurofins Air Toxics has successfully achieved ISO 17025 accreditation for its new Environmental Chamber emissions testing facility in Folsom, CA. Achieving this accreditation for accurate, consistent testing and calibration strengthens Eurofins’ worldwide leadership in Environmental Chamber emissions testing services.
For over two decades, environmental chambers have been used to test and measure manufacturers’ product/material volatile organic compounds (VOCs), including aldehyde, emissions. Reducing emission levels of these chemicals can positively impact indoor air quality and help achieve healthier indoor environments. The attainment of ISO 17025 accreditation demonstrates Eurofins Air Toxics’ capability to produce precise and consistent results down to the parts per billion level for clients. This will enable Eurofins Air Toxics to help manufacturers meet the growing customer demand for low emitting products and support their sustainability initiatives.
“Product manufacturers need a partner with the comprehensive portfolio to address a variety of global VOC testing requirements,” says Robert Mitzel, President of Eurofins Air Toxics. “Our investment in Environmental Chamber emissions testing technology in Folsom, combined with existing capabilities of our analytical laboratory to measure and detect chemicals, establishes Eurofins as a strong global solution provider for manufacturers.”
To remain competitive in a global market, product manufacturers need to be able to demonstrate that their products’ chemical emissions comply with numerous governmental regulations and green building related market requirements. To address this need, Eurofins Air Toxics’ ISO 17025 accreditation for chamber emissions testing encompasses US and international standards for testing and assessment from ASTM, ANSI, and ISO, helping manufacturers consolidate their testing programs to a single laboratory.
Eurofins began offering Environmental Chamber testing services in Galten, Denmark, in 1989. Since then, Eurofins increased the capacity of the Galten facility, opened a testing facility in Shenzhen, China, and added the testing services in Folsom, California, providing services on three continents. Product manufacturers may now use any of these laboratories to test their products in line with standardized testing programs, such as:
- CDPH SM V1.1 (CA 01350)
- ANSI BIFMA M7.1/X7.1
- French VOC Label Regulations
- VOC testing requirements of 3rd party IAQ certification programs
For more information about the Environmental Chamber emissions testing services available from Eurofins, please visit http://www.eurofinsus.com/industries/product_testing.html and http://www.eurofins.com/voc-contacts.aspx.
Notes for the editor:
About Eurofins Air Toxics
Founded in 1989 and based in Folsom, California, Air Toxics Inc. the leading US air testing laboratory, specializing in the analysis of air using a wide range of EPA, CARB, ASTM, and NIOSH methods. Its capabilities range from parts per trillion volume (pptv) analysis of ambient air to identifying organics in high level sources, and from routine analysis to sophisticated special technical services. A continuing commitment to data integrity, investment in advanced instrumentation and technologies, and dedicated client service have made Air Toxics the premier test facility for the analysis of air samples.
Notes for the editor:
Eurofins - a global leader in bio-analysis
Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.
With over 13,000 staff in more than 170 laboratories across 35 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results in time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
Important disclaimer: This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.